Hoffman-La Roche. Inc.

Pharmaceutical composition with improved bioavailability

Compositions and uses thereof

Inhibitors of bruton's tyrosine kinase

Processes for the manufacture of propane-1-sulfonic acid (3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl)-amide

Antiproliferative benzo [B] azepin-2-ones

Substituted isoxazole amide compounds as inhibitors of stearoyl-CoA desaturase 1 (SCD1)

MRNA-based gene expression for personalizing patient cancer therapy with an MDM2 antagonist

Nucleic acids encoding antibodies against human CSF-1R and uses thereof

N-alkyltriazole compounds as LPAR antagonists

2′, 4′-difluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication

1,3-oxazines as BACE1 and/or BACE2 inhibitors

Safety device for an injection syringe

Amino acid sequence presenting fusion polypeptide and its use

Arlethynyl derivatives

Antibodies against human angiopoietin 2

Solid forms of a pharmaceutically active substance

Bispecific antibodies comprising a disulfide stabilized-Fv fragment

Pyridazine amide compounds useful as SYK inhibitors

Thienopyrimidine compounds

Pharmaceutical dosage forms comprising valganciclovir hydrochloride

Bicyclic dihydroisoquinoline-1-one derivatives

Process for the preparation of isoxazolyl-methoxy nicotinic acids

Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol)

Cyclopropyl-fused-1,3-thiazepines as BACE1 and/or BACE2 inhibitors

Ethynyl compounds

Diazonium-free method to make an indazole intermediate in the synthesis of bicyclic 5-(trifluormethoxy)-1H-3-indazolecarboxylic acid amides

Nucleic acid molecules encoding anti-amyloid beta antibodies

Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents

Combination therapy for proliferative disorders

Quinolines

Enzymatic antibody processing

Azacyclic compounds

Purification and characterization of cytotoxic lymphocyte maturation factor and monoclonal antibodies thereto

Cancerous disease modifying antibodies

Quinolizidine and indolizidine derivatives

Tricyclic compounds

3,3-dimethyl tetrahydroquinoline derivatives

Nitrogen-containing heteroaryl derivatives

Delivery device for use with a therapeutic drug

Antibodies against human CSF-1R and uses thereof

Azacyclic derivatives

Spiroindolinone pyrrolidines

Purification of pegylated polypeptides

Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators

High dose oral formulation of bisphosphonate and a process for making thereof

Bicyclic compounds

Pyrrolidines as NK3 receptor antagonists

3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines

Piperidine derivatives

Cyclopentane derivatives

Compositions and uses thereof

Distinguishing assay

Proline derivatives

Process for the preparation of propionic acid derivatives

Substituted benzene compounds as modulators of the glucocorticoid receptor

Leukotriene B4 inhibitors

Substituted piperidines as somatostatin receptor subtype 5 (SSTR5) antagonists

Orlistat compositions

Heavy chain mutant leading to improved immunoglobulin production

Naphthylacetic acids

Pseudoproline dipeptides

Benzo[D]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine D3 receptors

5-substituted benzoxazines

Bi-aryl aminotetralines

Trimerising module

Imidazo [4,5-B] pyridine and pyrrolo [2,3-B] pyridine protein kinase inhibitors

5-amido-indole-2-carboxamide derivatives

Benzopyran and benzoxepin PI3K inhibitor compounds and methods of use

Spiroindolinone derivatives

2-aminoquinolines

4,5-dihydro-oxazol-2-yl amine derivatives

N-(2-amino-phenyl)-amide derivatives

Heterocyclic-substituted phenyl methanones

Aryl-isoxazolo-4-yl-oxadiazole derivatives

Antibodies for identifying and/or isolating at least one cell population

Bivalent, bispecific antibodies

Method for preparing enantiomerically pure 4-pyrrolidino phenylbenzyl ether derivatives

Spiroindolinone derivatives